Delivery Order SPE2DB20D3103-SPE2DB25FP6J0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,135.58. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,774.99 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,141.92 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Phytonadione...
- The Defense Logistics Agency awarded a delivery order valued at $10,741.92 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. Performance will take place at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. Phytonadione,...
- The Defense Logistics Agency awarded a delivery order valued at $1,350.84 to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,701.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Phytonadione 1 mg/0.5 ml syringe, a vitamin K medication, with a ceiling value of $1,425.42 and a period of performance through May 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,214.86 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes in 0.5 ml quantities, with final delivery due by August 12, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Phytonadione 1 mg/0.5 mL syrup, a Vitamin K medication, with a ceiling value of $11,567.66 and a performance period ending on August 27, 2024. The contract is a firm fixed-price delivery order, and no set-aside designation was used. AmerisourceBergen, through its corporate office division, is the prime...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6J0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. Phytonadione, also known as Vitamin K1, is a critical pharmaceutical used in medical settings for coagulation disorders and as an antidote to anticoagulant toxicity. AmerisourceBergen's role as a primary pharmaceutical distributor for the Defense Logistics Agency positions the company as a key supplier of essential medications to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contracting history demonstrates its capability to fulfill complex pharmaceutical procurement requirements across multiple therapeutic domains, supporting military readiness and veteran healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.6k | 7/24/25 |